4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000157
Chairperson & CEO sold 9,500 shares at an average $541.64 ($5,145,537)
- Chairperson & CEO acquired 9,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
ROTHBLATT MARTINE A · Chairperson & CEO
Table I: Non-derivative
12 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-10-05 | Exercise or conversion : show line 1 in the form 10b5-1 | +9,500 | $117.76 | $1,118,720 | 333,943 | I |
| 2026-10-05 | Sale : show line 2 in the form 10b5-1 | −501 | $536.26 | $268,665 | 333,442 | I |
| 2026-10-05 | Sale : show line 3 in the form 10b5-1 | −905 | $537.43 | $486,373 | 332,537 | I |
| 2026-10-05 | Sale : show line 4 in the form 10b5-1 | −655 | $538.62 | $352,795 | 331,882 | I |
| 2026-10-05 | Sale : show line 5 in the form 10b5-1 | −931 | $539.50 | $502,279 | 330,951 | I |
| 2026-10-05 | Sale : show line 6 in the form 10b5-1 | −1,028 | $540.50 | $555,633 | 329,923 | I |
| 2026-10-05 | Sale : show line 7 in the form 10b5-1 | −1,239 | $541.66 | $671,120 | 328,684 | I |
| 2026-10-05 | Sale : show line 8 in the form 10b5-1 | −918 | $542.56 | $498,067 | 327,766 | I |
| Open-market sales · 9,500 sh · avg $541.64 · $5,145,537 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-10-05 | Exercise or conversion : show line 13 in the form 10b5-1 Stock Option | −9,500 | 299,910 | I |
Loading xslF345X06/primarydocument.xml…